GOLM1 promotes prostate cancer progression through activating PI3K‐AKT‐mTOR signaling

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0045|78|3|166-177

ISSN： 0270-4137

Source： THE PROSTATE, Vol.78, Iss.3, 2018-02, pp. : 166-177

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/Akt/mTOR signaling pathway

By            

International Journal of Molecular Medicine, Vol. 35, Iss. 5, 2015-01 ,pp. : 1301-1308

Spandidos Publications

Access to resources Recommend Favorite

Puquitinib mesylate (XC-302) induces autophagy via inhibiting the PI3K/AKT/mTOR signaling pathway in nasopharyngeal cancer cells

By          

International Journal of Molecular Medicine, Vol. 36, Iss. 6, 2015-01 ,pp. : 1556-1562

Spandidos Publications

Access to resources Recommend Favorite

The PI3K/Akt/mTOR axis in head and neck cancer: functions, aberrations, cross‐talk, and therapies

By  

ORAL DISEASES, Vol. 21, Iss. 7, 2015-10 ,pp. : 815-825

John Wiley & Sons Inc

Access to resources Recommend Favorite

The PI3K/Akt/mTOR axis in head and neck cancer: functions, aberrations, cross‐talk, and therapies

By  

ORAL DISEASES, Vol. 1354-523X, Iss. 7, 2015-10 ,pp. : 815-825

John Wiley & Sons Inc

Access to resources Recommend Favorite

The PI3K/AKT/mTOR pathway is involved in direct apoptosis of CLL cells induced by ROR1 monoclonal antibodies

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 3, 2015-05 ,pp. : 455-458

John Wiley & Sons Inc

Access to resources Recommend Favorite